Related Experiment Video
Updated: May 5, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Acute and subacute drug-induced movement disorders
1Movement Disorders Unit, Department of Neurology, Geneva University Hospitals, Switzerland.
Many drugs can cause movement disorders like dystonia and parkinsonism. Identifying these drug-induced movement disorders relies on medication history and symptom patterns for proper diagnosis and management.
Area of Science:
- Neurology
- Pharmacology
Background:
- Pharmacological agents can induce diverse movement disorders with varying timelines.
- These motor symptoms may occur independently or as part of broader neurological or systemic conditions.
Purpose of the Study:
- To review acute and subacute drug-induced movement disorders.
- To highlight key features for identification and diagnostic approaches.
Main Methods:
- Review of literature focusing on drug-induced movement disorders.
- Analysis of common etiological agents and underlying neurochemical mechanisms.
Main Results:
- Commonly implicated medications include dopamine receptor blockers, antidepressants, and anti-epileptics.
- Key diagnostic features include temporal relationship to medication, dose-dependency, and resolution upon drug cessation (except tardive syndromes).
- Mechanisms involve alterations in basal ganglia neurotransmission (dopamine, serotonin, etc.).
Conclusions:
- Drug-induced movement disorders are identifiable through careful medication history and recognition of characteristic patterns.
- This review focuses on acute/subacute presentations like dystonic reactions, akathisia, parkinsonism, and associated syndromes.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Alterations in Muscle Tone ll

